<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9048665</article-id>
    <article-id pub-id-type="pmid">35289834</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btac157</article-id>
    <article-id pub-id-type="publisher-id">btac157</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Databases and Ontologies</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>RevUP: an online scoring system for regulatory variants implicated in rare diseases</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Correard</surname>
          <given-names>Solenne</given-names>
        </name>
        <aff><institution>Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, University of British Columbia</institution>, Vancouver, BC V5Z 4H4, <country country="CA">Canada</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hewitson</surname>
          <given-names>Brittany</given-names>
        </name>
        <aff><institution>Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, University of British Columbia</institution>, Vancouver, BC V5Z 4H4, <country country="CA">Canada</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7391-9438</contrib-id>
        <name>
          <surname>van der Lee</surname>
          <given-names>Robin</given-names>
        </name>
        <aff><institution>Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, University of British Columbia</institution>, Vancouver, BC V5Z 4H4, <country country="CA">Canada</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6098-6412</contrib-id>
        <name>
          <surname>Wasserman</surname>
          <given-names>Wyeth W</given-names>
        </name>
        <xref rid="btac157-cor1" ref-type="corresp"/>
        <!--wyeth@cmmt.ubc.ca-->
        <aff><institution>Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, University of British Columbia</institution>, Vancouver, BC V5Z 4H4, <country country="CA">Canada</country></aff>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Martelli</surname>
          <given-names>Pier Luigi</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btac157-cor1">To whom correspondence should be addressed. <email>wyeth@cmmt.ubc.ca</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>01</day>
      <month>5</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-03-15">
      <day>15</day>
      <month>3</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>15</day>
      <month>3</month>
      <year>2022</year>
    </pub-date>
    <volume>38</volume>
    <issue>9</issue>
    <fpage>2664</fpage>
    <lpage>2666</lpage>
    <history>
      <date date-type="received">
        <day>01</day>
        <month>10</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>03</day>
        <month>3</month>
        <year>2022</year>
      </date>
      <date date-type="editorial-decision">
        <day>05</day>
        <month>3</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>14</day>
        <month>3</month>
        <year>2022</year>
      </date>
      <date date-type="corrected-typeset">
        <day>01</day>
        <month>4</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btac157.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>To address the difficulty in assessing the implication of regulatory variants in diseases, a scoring scheme previously published allows the calculation of the Regulatory Variant Evidence score (RVE-score). The score represents the accumulated evidence for a causative role of a regulatory variant in a disease. Regulatory Evidence for Variants Underlying Phenotypes was built to calculate the RVE-score of regulatory variants, based on the 24 criteria, with a hybrid approach combining information retrieved from public databases and user input.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>RevUP is freely available at <ext-link xlink:href="http://www.revup-classifier.ca" ext-link-type="uri">http://www.revup-classifier.ca</ext-link>. The source code is available at <ext-link xlink:href="https://github.com/wassermanlab/revup" ext-link-type="uri">https://github.com/wassermanlab/revup</ext-link>.</p>
      </sec>
      <sec id="s4">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Natural Sciences and Engineering Research Council of Canada Discovery Grant</institution>
          </institution-wrap>
        </funding-source>
        <award-id>RGPIN-2017-06824</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>BC Children’s Hospital Foundation &amp; Research Institute</institution>
          </institution-wrap>
        </funding-source>
        <award-id>KRZ48027</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Rubicon fellowship from the Netherlands Organization for Scientific Research [NWO</institution>
          </institution-wrap>
        </funding-source>
        <award-id>452172015</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>To date, several DNA variant classifiers are available and most are aligned to the American College of Medical Genetics and Genomics (ACMG) consensus recommendations (<xref rid="btac157-B12" ref-type="bibr">Richards <italic toggle="yes">et al.</italic>, 2015</xref>). Recently, recommendations were proposed for changes to the ACMG guidelines for clinical interpretation of variants to include variants found in non-coding regions of the genome, showing the relevance of such variants for genetic conditions (<xref rid="btac157-B4" ref-type="bibr">Ellingford <italic toggle="yes">et al.</italic>, 2021</xref>; <xref rid="btac157-B14" ref-type="bibr">Turner and Eichler, 2019</xref>).</p>
    <p>With the growing use of clinical whole-genome sequencing, there is a need for extension of the classification systems suitable for regulatory sequence variants. Diverse regulatory variant prediction methods have been developed, such as PRVCS (<xref rid="btac157-B10" ref-type="bibr">Li <italic toggle="yes">et al.</italic>, 2016</xref>) or GREEN-VARAN (<xref rid="btac157-B5" ref-type="bibr">Giacopuzzi <italic toggle="yes">et al.</italic>, 2020</xref>), have begun to aggregate predictions and prioritize variants expected to disrupt gene regulation. Such bioinformatics tools generally draw upon genomics databases for information, but often the strongest evidence is found in gene-specific publications. Furthermore, the focus on regulatory dysfunction does not necessarily relate to pathogenic impact, which is critical for clinical classification. In 2020, a review of 46 regulatory disease variants reported to disrupt the expression of 40 transcription factor genes generated a semiquantitative classification scheme that incorporates both functional and clinical evidence (<xref rid="btac157-B8" ref-type="bibr">van der Lee <italic toggle="yes">et al.</italic>, 2020</xref>). The scheme allows the calculation of the Regulatory Variant Evidence score (RVE-score), based on 24 criteria, which summarizes the accumulated evidence for a regulatory variant to have a causative role in a rare disease.</p>
    <p>Regulatory Evidence for Variants Underlying Phenotypes (RevUP, <ext-link xlink:href="http://www.revup-classifier.ca" ext-link-type="uri">http://www.revup-classifier.ca</ext-link>), a web-based classifier, was built to calculate the RVE-score of regulatory variants, based on the 24 criteria presented in <xref rid="btac157-B8" ref-type="bibr">van der Lee <italic toggle="yes">et al.</italic> (2020)</xref>. Some previously released classifiers (not regulation focused) rely on user input only (<xref rid="btac157-B7" ref-type="bibr">Kleinberger <italic toggle="yes">et al.</italic>, 2016</xref>), while others rely uniquely on information available in public databases (<xref rid="btac157-B9" ref-type="bibr">Li and Wang, 2017</xref>), RevUP relies on both. The result page is a user-friendly display, downloadable and suitable for inclusion in a scientific report, together with a FAQ on the use of RevUP.</p>
  </sec>
  <sec>
    <title>2 Materials and methods</title>
    <sec>
      <title>2.1 Architecture and hosting</title>
      <p>RevUP is a web application composed of a front end written in React, and a backend framework written in Flask. It is hosted on Amazon Web Services using a t2.medium elastic compute (EC2) instance with Nginx being used as the web server to route traffic. All code for RevUP is available on GitHub <ext-link xlink:href="https://github.com/wassermanlab/revup" ext-link-type="uri">https://github.com/wassermanlab/revup</ext-link>.</p>
    </sec>
    <sec>
      <title>2.2 Scoring scheme</title>
      <p>The scoring scheme presented in <xref rid="btac157-B8" ref-type="bibr">van der Lee <italic toggle="yes">et al.</italic> (2020)</xref> is composed of a clinical component ‘Is there a causal link between genotype and phenotype?’ and a functional component ‘Does the variant have a damaging effect on the gene?’. Each evidence is given a score of 0 or 1 (0: The evidence does not apply to the variant or it is unknown; 1: The evidence applies to the variant, pondered based on the evidence weight). From the evidence, three scores are calculated: (i) the C-score, reflecting the clinical evidence available; (ii) the F-score, reflecting the functional evidence available and (iii) the RVE-score which is the accumulated evidence for a causative role of a regulatory variant in a disease. For some of the evidence, the information can be retrieved from public databases while other evidence requires user input (ex: C3.1, ‘Variant shows familial segregation with the disease’).</p>
    </sec>
    <sec>
      <title>2.3 User input on the variant and target gene (Step 1) and databases queried by the webserver</title>
      <p>For RevUP to query external databases, the user must input the variant details and the suspected target gene. Six external resources are then queried: PhyloP (<xref rid="btac157-B2" ref-type="bibr">Cooper <italic toggle="yes">et al.</italic>, 2005</xref>), PhastCons (<xref rid="btac157-B13" ref-type="bibr">Siepel <italic toggle="yes">et al</italic>., 2005</xref>), gnomAD (<xref rid="btac157-B6" ref-type="bibr">Karczewski <italic toggle="yes">et al</italic>., 2020</xref>), CADD (<xref rid="btac157-B11" ref-type="bibr">Rentzsch <italic toggle="yes">et al</italic>., 2019</xref>), ReMap (<xref rid="btac157-B1" ref-type="bibr">Chèneby <italic toggle="yes">et al</italic>., 2020</xref>) and ENCODE (<xref rid="btac157-B3" ref-type="bibr">Davis <italic toggle="yes">et al</italic>., 2018</xref>). The details on the versions used and the information retrieved can be found in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>.</p>
    </sec>
    <sec>
      <title>2.4 User input for additional evidence (Step 2)</title>
      <p>Some evidence cannot be found online. Others can be found using public databases but are too complicated to query automatically as they require interpretation by a human expert (ex: C2.1, ‘Suspected target gene has been implicated in the same or a similar disease phenotype, or is otherwise relevant’). Therefore, the user will have the ability to answer ‘Yes’ or ‘No’ to these questions in order for the tool to calculate the score.</p>
    </sec>
    <sec>
      <title>2.5 Results modification and comments (Step 3)</title>
      <p>Users may have additional evidence that was not available in the queried public databases, therefore, the user can modify the score for each evidence level as well as add comments. Comments were created to allow citations to relevant publications, or specific figures within publications (i.e. free text). It is not advised to change the scores unless the user has strong evidence to justify it.</p>
    </sec>
  </sec>
  <sec>
    <title>3 Results</title>
    <p>Based on the user input and on the values retrieved from the external databases, RevUP calculates the C-score, the F-score and the RVE-score for the submitted variant. The result page is composed of two parts. The top portion (<xref rid="btac157-F1" ref-type="fig">Fig. 1A</xref>) presents the information concerning the variant, the RVE-score and the strength of this score relative to the distribution of a curated collection of 46 regulatory variants (<xref rid="btac157-B8" ref-type="bibr">van der Lee <italic toggle="yes">et al.</italic>, 2020</xref>). This can indicate to the user if the score is high or low compared to published variants. Then, the C- and F-scores are displayed separately for the user to assess the strength and weakness of their analysis. The bottom portion (<xref rid="btac157-F1" ref-type="fig">Fig. 1B</xref>) indicates, for each evidence level, the score, the information outputted from public databases and the comments added by the user (if any). The results are downloadable in PDF or png formats to present as-is or in modified form.</p>
    <fig position="float" id="btac157-F1">
      <label>Fig. 1.</label>
      <caption>
        <p>RevUP report obtained for the scoring of the non-coding variant in the NOTCH1 gene reported by <xref rid="btac157-B15" ref-type="bibr">Wang <italic toggle="yes">et al</italic>. (2020)</xref> in proband 1. (<bold>A</bold>) Summary information for the variant; (<bold>B</bold>) clinical and functional information compiled from user input and external databases used to generate the RevUP score</p>
      </caption>
      <graphic xlink:href="btac157f1a" position="float"/>
    </fig>
    <p>An example is shown in <xref rid="btac157-F1" ref-type="fig">Figure 1</xref>, based on a recently published variant located in a regulatory region upstream of <italic toggle="yes">NOTCH1</italic> and implicated in the tetralogy of Fallot (<xref rid="btac157-B15" ref-type="bibr">Wang <italic toggle="yes">et al.</italic>, 2020</xref>). We input the variant characteristics and the information found in the paper in RevUP. The tool allowed for a quick scoring of the variant, and the creation of the displayed figure.</p>
  </sec>
  <sec>
    <title>4 Conclusions and outlook</title>
    <p>RevUP is a strong addition to the available variant classifier tools, as it will allow users to assess properties specific to regulatory variants. This scoring system does not conflict with the ACMG classification guidelines; rather it can be used as additional information when studying regulatory variants. The tool will save time for the user as it is able to query databases rapidly.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btac157_Supplementary_Data</label>
      <media xlink:href="btac157_supplementary_data.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>The authors thank current and past members of the Wasserman lab for helpful discussion and Dora Pak for management support.</p>
    <sec>
      <title>Funding</title>
      <p>This work was supported by funding from the Natural Sciences and Engineering Research Council of Canada Discovery Grant [RGPIN-2017-06824], the BC Children’s Hospital Foundation &amp; Research Institute [KRZ48027]; and a Rubicon fellowship from the Netherlands Organization for Scientific Research [NWO &amp; ZONMW, 452172015 to R.v.d.L.].</p>
      <p><italic toggle="yes">Conflict of Interest</italic>: none declared.</p>
    </sec>
  </ack>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btac157-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chèneby</surname><given-names>J.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>ReMap 2020: a database of regulatory regions from an integrative analysis of human and Arabidopsis DNA-binding sequencing experiments</article-title>. <source>Nucleic Acids Res</source>., <volume>48</volume>, <fpage>D180</fpage>–<lpage>D188</lpage>.<pub-id pub-id-type="pmid">31665499</pub-id></mixed-citation>
    </ref>
    <ref id="btac157-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cooper</surname><given-names>G.M.</given-names></string-name></person-group>  <etal>et al</etal>; NISC Comparative Sequencing Program. (<year>2005</year>) <article-title>Distribution and intensity of constraint in mammalian genomic sequence</article-title>. <source>Genome Res</source>., <volume>15</volume>, <fpage>901</fpage>–<lpage>913</lpage>.<pub-id pub-id-type="pmid">15965027</pub-id></mixed-citation>
    </ref>
    <ref id="btac157-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname><given-names>C.A.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>The Encyclopedia of DNA elements (ENCODE): data portal update</article-title>. <source>Nucleic Acids Res</source>., <volume>46</volume>, <fpage>D794</fpage>–<lpage>D801</lpage>.<pub-id pub-id-type="pmid">29126249</pub-id></mixed-citation>
    </ref>
    <ref id="btac157-B4">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Ellingford</surname><given-names>J.M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2021</year>) Recommendations for clinical interpretation of variants found in non-coding regions of the genome. medRxiv 2021.12.28.21267792</mixed-citation>
    </ref>
    <ref id="btac157-B5">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Giacopuzzi</surname><given-names>E.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) GREEN-DB: a framework for the annotation and prioritization of non-coding regulatory variants in whole-genome sequencing. bioRxiv 2020.09.17.301960.</mixed-citation>
    </ref>
    <ref id="btac157-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karczewski</surname><given-names>K.J.</given-names></string-name></person-group>  <etal>et al</etal>; Genome Aggregation Database Consortium. (<year>2020</year>) <article-title>The mutational constraint spectrum quantified from variation in 141,456 humans</article-title>. <source>Nature</source>, <volume>581</volume>, <fpage>434</fpage>–<lpage>443</lpage>.<pub-id pub-id-type="pmid">32461654</pub-id></mixed-citation>
    </ref>
    <ref id="btac157-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kleinberger</surname><given-names>J.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2016</year>) <article-title>An openly available online tool for implementing the ACMG/AMP standards and guidelines for the interpretation of sequence variants</article-title>. <source>Genet. Med</source>., <volume>18</volume>, <fpage>1165</fpage>.<pub-id pub-id-type="pmid">26986878</pub-id></mixed-citation>
    </ref>
    <ref id="btac157-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>K.</given-names></string-name></person-group> (<year>2017</year>) <article-title>InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines</article-title>. <source>Am. J. Hum. Genet</source>., <volume>100</volume>, <fpage>267</fpage>–<lpage>280</lpage>.<pub-id pub-id-type="pmid">28132688</pub-id></mixed-citation>
    </ref>
    <ref id="btac157-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>M.J.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2016</year>) <article-title>Predicting regulatory variants with composite statistic</article-title>. <source>Bioinformatics (Oxford, Engl.)</source>, <volume>32</volume>, <fpage>2729</fpage>–<lpage>2736</lpage>.</mixed-citation>
    </ref>
    <ref id="btac157-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rentzsch</surname><given-names>P.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>CADD: predicting the deleteriousness of variants throughout the human genome</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>D886</fpage>–<lpage>D894</lpage>.<pub-id pub-id-type="pmid">30371827</pub-id></mixed-citation>
    </ref>
    <ref id="btac157-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Richards</surname><given-names>S.</given-names></string-name></person-group>  <etal>et al</etal>; ACMG Laboratory Quality Assurance Committee. (<year>2015</year>) <article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source>Genet. Med</source>., <volume>17</volume>, <fpage>405</fpage>–<lpage>424</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
    </ref>
    <ref id="btac157-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Siepel</surname><given-names>A.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2005</year>) <article-title>Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes</article-title>. <source>Genome Res</source>., <volume>15</volume>, <fpage>1034</fpage>–<lpage>1050</lpage>.<pub-id pub-id-type="pmid">16024819</pub-id></mixed-citation>
    </ref>
    <ref id="btac157-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Turner</surname><given-names>T.N.</given-names></string-name>, <string-name><surname>Eichler</surname><given-names>E.E.</given-names></string-name></person-group> (<year>2019</year>) <article-title>The role of de novo noncoding regulatory mutations in neurodevelopmental disorders</article-title>. <source>Trends Neurosci</source>., <volume>42</volume>, <fpage>115</fpage>–<lpage>127</lpage>.<pub-id pub-id-type="pmid">30563709</pub-id></mixed-citation>
    </ref>
    <ref id="btac157-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Van der Lee</surname><given-names>R.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>Deregulated regulators: disease-causing cis variants in transcription factor genes</article-title>. <source>Trends Genet</source>., <volume>36</volume>, <fpage>523</fpage>–<lpage>539</lpage>.<pub-id pub-id-type="pmid">32451166</pub-id></mixed-citation>
    </ref>
    <ref id="btac157-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>Family-based whole-genome sequencing identifies compound heterozygous protein-coding and noncoding mutations in tetralogy of Fallot</article-title>. <source>Gene</source>, <volume>741</volume>, <fpage>144555</fpage>.<pub-id pub-id-type="pmid">32165302</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
